PB 30 of 2019
National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 4)
National Health Act 1953
___________________________________________________________________________
I, SEAN LANE, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 29 April 2019
SEAN LANE
Assistant Secretary (Acting)
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
1 Name of Instrument
(1) This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 4).
(2) This Instrument may also be cited as PB 30 of 2019.
2 Commencement
This Instrument commences on 1 May 2019.
3 Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)
Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).
Schedule 1 Amendments
[1] Schedule 1, after entry for Oxybutynin in the form Transdermal patches 36 mg, 8
insert:
Palbociclib | Capsule 75 mg | 20 | 21 | 5 |
|
| Capsule 100 mg | 20 | 21 | 5 |
|
| Capsule 125 mg | 20 | 21 | 5 |
|
[2] Schedule 1, after entry for Tiotropium with olodaterol
insert:
Tofacitinib | Tablet 5 mg | 20 | 56 | 5 |
|